TP53 and cancer: Additionally, the KEGG enrichment analysis showed that DEGs were enriched in several tumor-related pathways such as proteoglycans in cancer, pathways in cancer, transcriptional misregulation in cancer, prostate cancer, and p53 signaling pathway (Figure 9B).